[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zura Bio Ltd (ZURA)

Zura Bio Ltd (ZURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zura Bio Ltd 1489 W. Warm Springs Road Suite 110 Henderson NV 89014 USA

https://zurabio.com Employees: 40 P: 702-825-9872

Sector:

Medical

Description:

Zura Bio Limited is a clinical-stage biotechnology company advancing primary assets, including ZB-168 in Alopecia Areata and other inflammatory diseases and torudokimab in both chronic obstructive pulmonary disease and asthma. Zura Bio Limited, formerly known as JATT Acquisition Corp, is headquartered in London, UK.

Key Statistics

Overview:

Market Capitalization, $K 548,412
Enterprise Value, $K 439,002
Shares Outstanding, K 94,881
Float, K 83,144
% Float 87.63%
Short Interest, K 10,253
Short Float 10.81%
Days to Cover 9.52
Short Volume Ratio 0.65
% of Insider Shareholders 12.37%
% of Institutional Shareholders 61.14%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -99,350 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,220 K
EBIT, $ -81,490 K
EBITDA, $ -81,440 K

Growth:

1-Year Return 254.09%
3-Year Return -16.72%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 05/07/26
Next Earnings Date 11/12/26
Earnings Per Share ttm -1.09
EPS Growth vs. Prev Qtr 4.55%
EPS Growth vs. Prev Year -23.53%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ZURA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -61.47%
Return-on-Assets % -54.11%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.43
Book Value/Share 2.29
Interest Coverage -1.07
60-Month Beta -0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.